These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1119 related articles for article (PubMed ID: 31409081)
21. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
22. Absence of genomic BRCA1 and BRCA2 rearrangements in Ashkenazi breast and ovarian cancer families. Stadler ZK; Saloustros E; Hansen NA; Schluger AE; Kauff ND; Offit K; Robson ME Breast Cancer Res Treat; 2010 Sep; 123(2):581-5. PubMed ID: 20221693 [TBL] [Abstract][Full Text] [Related]
23. BRCA1 and BRCA2 mutations in a sample of breast and ovarian cancer families from the Colombian pacific. Cifuentes-C L; Rivera-Herrera AL; Barreto G Colomb Med (Cali); 2019 Sep; 50(3):163-175. PubMed ID: 32284662 [TBL] [Abstract][Full Text] [Related]
24. BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil. Mazzonetto P; Milanezi F; D'Andrea M; Martins S; Monfredini PM; Dos Santos Silva J; Perrone E; Villela D; Schnabel B; Nakano V; Palmero EI; Braggio E; Cavalcanti TL; Guida G; Migliavacca MP; Scapulatempo-Neto C; Zalcberg I Breast Cancer Res Treat; 2023 May; 199(1):127-136. PubMed ID: 36881271 [TBL] [Abstract][Full Text] [Related]
25. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families. Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759 [TBL] [Abstract][Full Text] [Related]
26. Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania. Janavičius R; Rudaitis V; Mickys U; Elsakov P; Griškevičius L Cancer Genet; 2014 May; 207(5):195-205. PubMed ID: 25066507 [TBL] [Abstract][Full Text] [Related]
27. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study. Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294 [TBL] [Abstract][Full Text] [Related]
28. Germline variants profiling of BRCA1 and BRCA2 in Chinese Hakka breast and ovarian cancer patients. Zhang Y; Wu H; Yu Z; Li L; Zhang J; Liang X; Huang Q BMC Cancer; 2022 Aug; 22(1):842. PubMed ID: 35918668 [TBL] [Abstract][Full Text] [Related]
29. A novel BRCA1 duplication and new insights on the spectrum and frequency of germline large genomic rearrangements in BRCA1/BRCA2. Sahin I; Saat H Mol Biol Rep; 2021 Jun; 48(6):5057-5062. PubMed ID: 34146199 [TBL] [Abstract][Full Text] [Related]
30. BRCA1 and BRCA2 germline mutations screening in Algerian breast/ovarian cancer families. Cherbal F; Bakour R; Adane S; Boualga K; Benais-Pont G; Maillet P Dis Markers; 2010; 28(6):377-84. PubMed ID: 20683152 [TBL] [Abstract][Full Text] [Related]
31. Germline mutations in BRCA1 and BRCA2 in breast-ovarian families from a breast cancer risk evaluation clinic. Martin AM; Blackwood MA; Antin-Ozerkis D; Shih HA; Calzone K; Colligon TA; Seal S; Collins N; Stratton MR; Weber BL; Nathanson KL J Clin Oncol; 2001 Apr; 19(8):2247-53. PubMed ID: 11304778 [TBL] [Abstract][Full Text] [Related]
32. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations]. Duan RR; Sun LX; Zhao HW Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292 [No Abstract] [Full Text] [Related]
33. Prevalence of BRCA1/BRCA2 mutations in a Brazilian population sample at-risk for hereditary breast cancer and characterization of its genetic ancestry. Fernandes GC; Michelli RA; Galvão HC; Paula AE; Pereira R; Andrade CE; Felicio PS; Souza CP; Mendes DR; Volc S; Berardinelli GN; Grasel RS; Sabato CS; Viana DV; Mauad EC; Scapulatempo-Neto C; Arun B; Reis RM; Palmero EI Oncotarget; 2016 Dec; 7(49):80465-80481. PubMed ID: 27741520 [TBL] [Abstract][Full Text] [Related]
34. Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany. Meyer P; Voigtlaender T; Bartram CR; Klaes R Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938098 [TBL] [Abstract][Full Text] [Related]
35. BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance. Eccles DM; Mitchell G; Monteiro AN; Schmutzler R; Couch FJ; Spurdle AB; Gómez-García EB; Ann Oncol; 2015 Oct; 26(10):2057-65. PubMed ID: 26153499 [TBL] [Abstract][Full Text] [Related]
36. Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel. Tung N; Battelli C; Allen B; Kaldate R; Bhatnagar S; Bowles K; Timms K; Garber JE; Herold C; Ellisen L; Krejdovsky J; DeLeonardis K; Sedgwick K; Soltis K; Roa B; Wenstrup RJ; Hartman AR Cancer; 2015 Jan; 121(1):25-33. PubMed ID: 25186627 [TBL] [Abstract][Full Text] [Related]
37. BRCA germline mutations in an unselected nationwide cohort of Chinese patients with ovarian cancer and healthy controls. Li A; Xie R; Zhi Q; Deng Y; Wu Y; Li W; Yang L; Jiao Z; Luo J; Zi Y; Sun G; Zhang J; Shi Y; Liu J Gynecol Oncol; 2018 Oct; 151(1):145-152. PubMed ID: 30078507 [TBL] [Abstract][Full Text] [Related]
38. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants. Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660 [TBL] [Abstract][Full Text] [Related]
39. Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil. Maistro S; Teixeira N; Encinas G; Katayama ML; Niewiadonski VD; Cabral LG; Ribeiro RM; Gaburo Junior N; de Gouvêa AC; Carraro DM; Sabino EC; Diz MD; Chammas R; de Bock GH; Folgueira MA BMC Cancer; 2016 Dec; 16(1):934. PubMed ID: 27914478 [TBL] [Abstract][Full Text] [Related]
40. A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland. McVeigh TP; Sweeney KJ; Brennan DJ; McVeigh UM; Ward S; Strydom A; Seal S; Astbury K; Donnellan P; Higgins J; Keane M; Kerin MJ; Malone C; McGough P; McLaughlin R; O'Leary M; Rushe M; Barry MK; MacGregor G; Sugrue M; Yousif A; Al-Azawi D; Berkeley E; Boyle TJ; Connolly EM; Nolan C; Richardson E; Giffney C; Doyle SB; Broderick S; Boyd W; McVey R; Walsh T; Farrell M; Gallagher DJ; Rahman N; George AJ Fam Cancer; 2023 Apr; 22(2):135-149. PubMed ID: 36029389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]